Check out this evening’s top movers from around Wall Street, compiled by The Fly.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
HIGHER –
- Processa Pharmaceuticals (PCSA) up 21.8% after announcing it has dosed in Phase 2 clinical trial of NGC-Cap for MBC
- Fidelity National Financial (FNF) up 2.1% after acquiring First Nationwide Title Agency
- Apollo Global Management (APO) up 1.7% after buying minority stake in Vonovia for EUR 1B
- Southwest Airlines (LUV) up 1.7% after insider buying activity
DOWN AFTER EARNINGS –
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PCSA:
- Processa Pharmaceuticals jumps 28% after Phase 2 study update
- Processa: First patient dosed in Phase 2 clinical trial of NGC-Cap for MBC
- Processa Pharmaceuticals reports Q2 EPS ($1.01) vs. ($1.94) last year
- Processa Pharmaceuticals announces preclinical data for NGC-Iri
- Processa Pharmaceuticals price target lowered to $6 from $8 at H.C. Wainwright